LXR receptor modulators
US7872021B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2006 |
| Grant date | Jan 18, 2011 |
| Priority date | — |
| Expiry date | Jun 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Benzenesulfonamide derivative compounds corresponding to the general formula (I):and their pharmaceutically acceptable addition salts; a process for preparation of such compounds; pharmaceutical compositions containing such compounds, and the use of such compounds as a pharmacologically active substance, in particular in the treatment of neurodegenerative diseases, cardiovascular diseases, inflammatory diseases; hypercholesterolemia, and diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.